Results 201 to 210 of about 1,087,727 (251)
Telomere-to-telomere genome assembly and a pangenome for the rat. [PDF]
Li K +12 more
europepmc +1 more source
Genome-Wide Association Studies in Hepatocellular Carcinoma: Aetiology-Specific Susceptibility, Functional Interpretation, and Clinical Translation. [PDF]
Zhang S, Long X.
europepmc +1 more source
Identification of a persistent Ascaris-derived Kalirin epitope associated with chronic T cell activation in the lung. [PDF]
Wu Y, Versteeg L, Wu MC, Weatherhead JE.
europepmc +1 more source
Rare Variants May Influence Disease Risk and Clinical Features in Sporadic Late-Onset Chinese Parkinson's Disease Patients. [PDF]
Ho RW +7 more
europepmc +1 more source
Moonlighting ERAP Aminopeptidases in Cancer: Beyond Antigen Processing. [PDF]
Gragera P, Scaldaferri V, Fruci D.
europepmc +1 more source
Innate Immune Cells in Non-Small Cell Lung Cancer: Roles in Tumor Progression and Therapeutic Responses. [PDF]
Liu J +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Minor histocompatibility antigens
Current Opinion in Immunology, 1997The existence of transplantation antigens, in addition to those encoded by genes in the MHC, has been known for over half a century. The molecular identification of these additional minor histocompatibility (H) antigens lagged behind that of their MHC counterparts, largely because minor H antigens are recognised by T cells and not by antibodies. In the
Simpson, E, Roopenian, D C
openaire +3 more sources
Minor Histocompatibility Antigens in GVL
2000In syngeneic bone marrow transplantation (BMT) and in recipients of autologous BMT, relapse rates are high. No MHC or minor histocompatibility antigen (mHag) disparities exist and thus no alloreactivities can be induced. This is clearly different in allogeneic BMT, where the relapse rates are significantly lower and a relationship is seen between the ...
Mutis, Tuna, Goulmy, Els
+7 more sources

